Home | Symbol Index | About |
Wed, 14 Jun 2006 5:00:00 PDT
MONTREAL, QUEBEC (MARKET WIRE) Ambrilia Biopharma Inc. (TSX: AMB), a biopharmaceutical company developing innovative therapeutics in the fields of cancer and infectious diseases, presented today a scientific poster reporting on the high genetic barrier and favorable cross-resistance profile of its lead HIV protease inhibitor (PI) PPL-100 at the 15th International HIV Drug Resistance Workshop, in Sitges, Spain.
Trackbacks
A trackback is a mechanism for communication between blogs. The following blog entries have been detected that are in reference to Ambrilia Biopharma Inc.: Ambrilia Presents Data Showing High Genetic Barrier to its Lead HIV Inhibitor PPl-100 at the 15th International HIV Drug Resistance Workshop.
- No trackbacks have been detected.
What is a Stock Cloud?
A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.